These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Rapid detection of Vibrio cholerae 0139 in faecal specimens by coagglutination. Agarwal V; Biswas M; Pathak AA; Saoji AM Indian J Med Res; 1995 Feb; 101():55-6. PubMed ID: 7729848 [TBL] [Abstract][Full Text] [Related]
23. Suppression of growth of Vibrio cholerae in the intestine of immunized mice. Knop J; Bellamy JE Med Microbiol Immunol; 1976 Jun; 162(2):153-8. PubMed ID: 934024 [TBL] [Abstract][Full Text] [Related]
24. An epidemic of cholera due to Vibrio cholerae O139 in Dhaka, Bangladesh: clinical and epidemiological features. Mahalanabis D; Faruque AS; Albert MJ; Salam MA; Hoque SS Epidemiol Infect; 1994 Jun; 112(3):463-71. PubMed ID: 8005212 [TBL] [Abstract][Full Text] [Related]
25. Modifications of the local immune response to Vibrio cholerate attributed to the intestinal microbial flora of the mouse. Horsfall DJ; Rowley D Aust J Exp Biol Med Sci; 1978 Oct; 56(5):579-86. PubMed ID: 156020 [TBL] [Abstract][Full Text] [Related]
26. [Cases of gastroenteritis associated to Vibrio cholerae no 01 in Oran, Salta]. Rivas M; Cacace ML; Ayala LT; Baschkier A; Miliwebsky E; Caffer MI Rev Argent Microbiol; 1996; 28(4):163-9. PubMed ID: 9102658 [TBL] [Abstract][Full Text] [Related]
27. [Detection of convalescent Vibrio cholerae carriers using the enterotest]. Grados P; Battilana C Bol Oficina Sanit Panam; 1994 Apr; 116(4):285-9. PubMed ID: 8037848 [TBL] [Abstract][Full Text] [Related]
28. Cholera in a developing megacity; Karachi, Pakistan. Sheikh A; Khan A; Malik T; Fisher-Hoch SP Epidemiol Infect; 1997 Dec; 119(3):287-92. PubMed ID: 9440430 [TBL] [Abstract][Full Text] [Related]
29. Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae. Sack RB; Miller CE J Bacteriol; 1969 Sep; 99(3):688-95. PubMed ID: 5370274 [TBL] [Abstract][Full Text] [Related]
30. [The possibility of colonizing the intestines of white mice with Lactobacillus acidophilus during bacterial therapy]. Kruglikov VD; Tsuraeva RI; Ryzhko IV; Drobotkovskaia NV; Kuchin VV; Bardykh ID; Pushkareva ND Zh Mikrobiol Epidemiol Immunobiol; 1997; (1):67-9. PubMed ID: 9221664 [TBL] [Abstract][Full Text] [Related]
31. Effect of a Lactobacillus animalis strain on composition and metabolism of the intestinal microflora in adult dogs. Biagi G; Cipollini I; Pompei A; Zaghini G; Matteuzzi D Vet Microbiol; 2007 Sep; 124(1-2):160-5. PubMed ID: 17462835 [TBL] [Abstract][Full Text] [Related]
32. A Mesocosm of Lactobacillus johnsonii, Bifidobacterium longum, and Escherichia coli in the mouse gut. Denou E; Rezzonico E; Panoff JM; Arigoni F; Brüssow H DNA Cell Biol; 2009 Aug; 28(8):413-22. PubMed ID: 19534605 [TBL] [Abstract][Full Text] [Related]
33. Aetiology of cholera in Tamil Nadu: recent observations. Sundaram SP; Revathi J; Elango V; Shanthakumari SL Trans R Soc Trop Med Hyg; 1998; 92(2):164-5. PubMed ID: 9764321 [TBL] [Abstract][Full Text] [Related]
34. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509 [TBL] [Abstract][Full Text] [Related]
35. [Assessment of antagonistic activity in vitro Lactobacillus spp. strains againts Clostridum difficile strains isolated from gastrointestinal tract of patients hospitalized in three hospitals in region Mazovia]. Skopińska E; Lachowicz D; Wultańska D; Pawłowska J; Jedrzejewska A; Obuch-Woszczatyński P; Pituch H Med Dosw Mikrobiol; 2012; 64(2):109-14. PubMed ID: 23072055 [TBL] [Abstract][Full Text] [Related]
36. Antibacterial immunity to Vibrio cholerae in rats. Cooper GN; Narendranathan R J Med Microbiol; 1986 Sep; 22(2):133-41. PubMed ID: 3746875 [TBL] [Abstract][Full Text] [Related]
37. Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae O139 infection: comparison with V. cholerae O1 infection. Dhar U; Bennish ML; Khan WA; Seas C; Huq Khan E; Albert MJ; Abdus Salam M Trans R Soc Trop Med Hyg; 1996; 90(4):402-5. PubMed ID: 8882188 [TBL] [Abstract][Full Text] [Related]
38. Epidemiology & molecular biology of Vibrio cholerae O139 Bengal. Albert MJ Indian J Med Res; 1996 Jul; 104():14-27. PubMed ID: 8783504 [TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of non-O1/non-O139 Vibrio cholerae isolates and polymerase chain reaction analysis of their virulence factors. Lee YL; Hung PP; Tsai CA; Lin YH; Liu CE; Shi ZY J Microbiol Immunol Infect; 2007 Dec; 40(6):474-80. PubMed ID: 18087626 [TBL] [Abstract][Full Text] [Related]
40. Emergence of multiple drug resistance Vibrio cholerae O1 in East Delhi. Das S; Choudhry S; Saha R; Ramachandran VG; Kaur K; Sarkar BL J Infect Dev Ctries; 2011 Apr; 5(4):294-8. PubMed ID: 21537071 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]